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Differentiation of Mouse Embryonic Stem Cells to
Lympho-Hematopoietic Lineages In Vitro
UNA CHEN
Basel Institute for Immunology, CH-4005 Basel, Switzerland
Mouse embryonic stem (ES) cells can differentiate in culture to late stages of many cell
lineages. have found culture conditions that are favorable for development in vitro of
ES cells into hematopoietic cells at a stage equivalent to day I1-14 of fetal liver
development. describe here (1) the growth conditions necessary for maintenance of ES
cells in an undifferentiated state, and the conditions that allow differentiation of cystic
embryoid bodies that contain precursors of most hematopoietic cell lineages, including
lymphoid cells; (2) the development of lymphoid vessels from ES fetuses in vivo; (3) the
characterization of lymphoid, erythroid, megakaryoid, and myeloid cells from ES
fetuses; and (4) the cloning of cell lines representing lymphoid, myeloid lineage cells
from differentiated ES cells.
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INTRODUCTION
Mouse embryonic stem cells (ES) derived from
the inner cell mass (ICM) stage of embryogenesis
retain their totipotency in vivo and in vitro
(Gossler et al., 1986; Doetschman et al., 1987;
Thompson et al., 1989; Koller and Smithies, 1989;
Schwartzberg et al., 1989; Zijlstra et al., 1989;
DeChiara et al., 1990; Koller et al., 1990). In vitro,
ES cells differentiate into endoderm, ectoderm,
and mesoderm (Martin and Evans, 1975; Martin,
1977; Robertson, 1987). The development in vitro
of blood island or erythropoietic stem cells equi-
valent to the yolk sac stage (i.e., day 8-10 of
embryogenesis) has been reported (Doetschman
et al., 1985; Gossler et al., 1986; Robertson, 1987).
Furthermore, erythroid and myeloid lineages
containing megakaryocytes were also obtained
by Cudennec and Johnson (1981) while studying
the differentiation of teratocarcinoma cells in
vitro. Recently, the mechanism of developmental
regulation of the ]/-globin was studied with ES
cells in vitro (Lindenbaum and Grosveld, 1990;
Wiles and Keller, 1991; Schmitt et al., 1991).
The origin of the pluripotent stem cells and
their lineage commitment’to lymphocytes from
mouse embryos are important issues in develop-
mental biology that have recently received much
attention. Stem cells from yolk sacs have been
shown to give rise to erythrocytes, megakaryotic
cells, and myeloid cells (Labastie et al., 1984). B
lymphocytes can also be found after yolk sac
stem cells are transferred into animals, but not in
in vitro differentiation condition (Melchers, 1977;
Paige et al., 1979; Melchers and Abramczuk,
1980; Chris Paige, personal communication). On
the other hand, stem cells obtained from the fetal
liver can give rise to erythroid, myeloid, and
B-lymphoid cells in vitro (Owen et al., 1975;
Melchers, 1977; Ogawa et al., 1988; Rolink et al.,
1991). Differentiation of T-lymphoid cells
requires a thymic microenvironment (see review
by von Boehmer, 1990).
Pluripotent stem cells have been difficult to
study because they are rare cells found in the het-
erogeneous cellular populations of bone marrow
and fetal liver. Great progress has been made in
obtaining subpopulations of bone marrow from
adult and fetal liver that are highly enriched for
pluripotent stem cells. Yet, very little is known
about how stem cells commit to differentiation
and how stem cells self-maintain. This lack of
knowledge is at least partially due to the inability
to maintain stem cells in vitro. Culture systems
that would allow the growth of very primitive
stem cells, such as mouse embryonic stem cells
and the primitive hematopoietic stem cells,
would be invaluable in addressing these issues.
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The liquid culture system described in this
study allows the development of pluripotent
hematopoietic stem cells and. all known hemato-
poietic lineages, including lymphoid (T and B)
lineages from ES cells. Because this is an import-
ant step for studying lymphohematopoiesis in
vitro, and because any deviation from the culture
condition described in this study did not give
rise to lymphocytes, I therefore describe in detail
the differentiation conditions, as well as the
growth conditions important for maintaining
undifferentiated ES cells.
Differentiation in vitro can be followed under
the microscope by observing the growing cells in
three dimensions. First, they form simple
embryoid bodies within clusters of cells and then
cystic embryoid bodies with a complicated inner
structure are developed. Finally, the embryoid
bodies become "ES fetuses," which contain pul-
sating cardiac muscle, yolk sac blood islands,
and, in addition, novel cup-shaped structures
containing lymphoid cells. Further development
of these ES fetuses was seen following introduc-
tion under the kidney capsule of young adult
mice. From selected "ES fetuses," I use a variety
of techniques to establish lymphoid and myeloid
cell lines.
RESULTS
Differentiation of ES Cells to Simple, Then
Cystic Embryoid Bodies, and the Selection of
ES Fetuses Among Cystic Embryoid Bodies
Mouse ES cells derived from strains 129 (ES-D3)
and C57B1/6 (ES-B6) grow two dimensionally on
top of nondividing feeder cells, which are pri-
mary embryonic fibroblasts. ES cells were
removed from feeder cells and allowed to differ-
entiate in a liquid suspension culture. Within
24 hr, the cells aggregate and small round struc-
tures are formed. After 4-5 days, an outer layer
of large endoderm cells is formed; some of them
develop cavities. An inner layer of "ectodermal-
like" cells is formed. These are simple embryoid
bodies. From 8 to 30 days, there is a more compli-
cated internal structure, which includes several
easily recognizable mesodermal tissues such as
blood cell clusters and cardiaclike tissue. These
are cystic embryoid bodies (Martin and Evans,
1975; Cudennec and Nicolas, 1977; Doetschman
et al., 1985; Gossler et al., 1986; Robertson, 1987).
Depending on the origin of the ES cell line and
the number of passages in culture, about 0.1-1%
of the ES cells develop into cystic embryoid
bodies. Under the liquid culture condition
described in the Materials and Methods section,
which allows a slow and free movement of
embryoid bodies, I found that about 30-40% of
the cystic embryoid bodies develop into "ES
fetuses" (Fig. 1). The ES fetuses differentiated 10x
more efficiently in the hydrophobic Heraeus tis-
sue culture dish than the bacterial culture dish
(see Materials and Methods section for source of
dish). Fully formed cystic embryoid bodies,
referred to as ES fetuses, are characterized by the
presence of pulsating cardiac muscle, yolk sac
blood islands, and, most importantly, the cup-
shaped structures (large arrows in Fig. 1) con-
taining small round 7-1O-tm diameter lymphoid-
like cells (small arrows in Fig. 1). They can be
selected at various growth stages of differen-
tiation from day 11 to 30.
Characterization of ES Fetuses In Vitro and In
Vivo
ES fetuses that were identified and selected
under the phase contrast microscope, Figs. 2(A)
and 2(B), were characterized histologically. As
shown in Fig. 2(C), cardiac muscle cells and the
cavity formed by the epithelium cells (cup-shape
structure under the microscope) are visible. The
clusters of cells inside the cavity shown in Fig.
2(D) are identified to be erythroid cells (arrow 5),
myeloid cells (arrow 2 and arrow 4), and lymph-
oid cells (arrow 1).
ES fetuses were subsequently implanted under
the kidney capsules of male Balb/c nude mice for
3 weeks, excised, and frozen. As shown in Figs.
2(E) to 2(I), immunophenotyping of the cryosec-
tions was performed. The sections were double
stained for anti-H-2K
b (conjugated to Texas Red,
to demonstrate the class-I haplotype of ES origin)
plus either anti-CD3 (conjugated to FITC) or anti-
/ (conjugated to FITC). Both T cells and B cells
were identified. T cells were identified in Figs.
2(F) and 2(G) by being positively stained with
anti-CD3 alone (green color in Fig. 2(F), solid
small arrow) or double stained with anti-CD3
plus anti-H-2K
b (orange color in Fig. 2(G), solid
small arrow). B cells were identified in Figs. 2(H)
and 2(I), by positively stained with anti-/ aloneLYMPHOCYTES DIFFERENTIATED FROM ES CELLS 33
Group
TABLE
Morphological Characterization of Lymphoid and Myeloid Cell Types Established from E$ Cells
Methods of Strain origin Cell types
immortalization Lym Mo RBC Mega Mono Platelet fat cells
A-MuLV 129, C57B1/6 + + + + +
2 J2 129 + + + +
3 RIM 129, C57B1/6 + + +
4 myc+mil 129 + + +
5 Growth factors 129, C57B1/6 + + + +
(IL-3, IL-2+ConA)
6 RIM+IL-3, 129, C57B1/6 -
+ + +
+IL-2+ConA
7 Growth factor IL-7 129 + + + + +
+ +
aStarting 2 weeks after retrovirus infection/lymphokine stimulation, the morphology of cell types was checked periodically for
6 months. The pattern of cell types was stable from about 4 weeks, if they were kept in the culture. Figure 3 shows representative
individual hematopoietic cell types established from ES cells.
bLym: 1.ymphocytes; Mo: macrophages; Mono: monocytes; Mega: megakaryocytes; RBC: erythrocytes.
example, the myc and mil oncogenes (Group 4)
produced cells mainly of the myeloid lineage.
The cells established with growth factors
(Groups 5 and 7) and J2 virus (Group 2) gave rise
to both lymphoid and myeloid cells. Abelson
(Group 1) and RIM viruses (Group 3) produced
the broadest spectrum of cell types. The combi-
nation of RIM virus and growth factors (Group 6)
established cell populations that differentiated
into plasma cells, and mature T-cells, in adoptive
transfer experiments (Chen et al., in preparation).
Characterization of Cell Types by Morphology
and In Situ Immunofluorescence
Cytocentrifuge preparations of each group were
evaluated following staining with Giemsa. Table
1 summarizes the diversity of cell types found in
each group after the establishment of stable cell
populations, which required a period of 4 weeks
to 6 months of culture. I started to examine the
morphology of the cell types 2 weeks after
"stimulation" (infection and/or growth factors)
and found that the phenotypes were stable from
4 weeks onwards. Figure 3 shows the mor-
phology of individual cells from one of these cul-
tures (Group 6). Cells with morphology charac-
teristic of monocytes (Fig 3, arrow 2) and
macrophages (Fig. 3, arrow 3) were observed,
and many of them were found to cluster around
erythrocytes (Fig. 3, arrows 5 and 5’). Mega-
karyocytes (Fig. 3, arrow 4) were also found to be
associated with these clusters. Lymphoidlike
cells (Fig. 3, arrow 1) with little cytoplasm and
dark-blue-staining nuclei were observed, either
in clusters or interspersed between irregularly
shaped, larger, light-blue-staining myeloid cells.
Cells grown in the presence of cytokines and
mitogens (Groups 5, 6, and 7) contained a signifi-
cant number of mitotic figures, and many of
them appeared to be irregular and contained
multiple vacuoles, possibly due to spontaneous
or virally induced transformation during long-
term culture (i.e., up to 6 months). Although the
FIGURE 2. Characterization of "ES fetuses." Phase-contrast photomicrographs of one ES fetus. (A) Low magnification (5x)
showing the whole body. C=cup-shape structure. H=heart. (B) Higher magnification (20x) focusing on a cup-shape structure
containing a red dot of cells in the middle (arrow). (C) Azura A-Eosin B staining of an ES fetus in plastic embedding from (A)
(low magnification, 5x). (D) Hematopoietic cells (magnification 100x) found in the cup-shape structure Shown in (C): arrow 1=
lymphocyte; arrow 2=monocyte; arrow 3=mitotic cell; arrow 4=megakaryocyte; and arrow 5=reticulocyte. (E) A Giemsa-stained
frozen section of ES fetus under the kidney capsular (arrow), excised from Balb/c nude mice 3 weeks after implantation
(magnification 3x). (F to I) Immunophenotyping of lymphocytes (solid small arrow) inside the lymphoid vessels (hollow large
arrow) from mature ES fetuses as shown in (E) (magnification 40x). The sections were stained with (F) FITC-labeled anti-CD3
arrow) and (G) anti-H-2K plus rat antimouse IgG-Texas Red (red color, hollow small arrow); antibody (green color, solid small
(G) when double stained (CD3/, H-2KD/), the color was orange (solid small arrow). The sections were also stained with (H) anti-/
conjugated with FITC (green color, solid small arrow) and (I) anti-H-2K
b/ plus rat antimouse IgG Texas Red (red color, hollow
small arrow); and (I) double stained (orange color, solid small arrow); (G and I) Note that some cells expressed only H-2K
surface antigen (red color, hollow small arrow). (See colour plate II at the back of this publication).LYMPHOCYTES DIFFERENTIATED FROM ES CELLS 35
FIGURE 4. Differentiated lymphoid cells derived from ES cells identified by staining of lymphoid-cell-surface markers by
indirect immunofluorescence microscopy. Photomicrographs of the cells from Group 6 (see Table 1). (A, C, and E)
Immunofluorescent staining. (B, D, and F) Corresponding phase-contrast photomicrographs. (A) B-lymphoid cells identified by
FITC-labeled sheep antimouse t-chain F(ab)’2 fragment. (C) T-lymphoid cells identified by anti-CD3 antibody (500-A2) and
second antibody of FITC-labeled rabbit antihamster IgG F(ab)’2 fragment. (E) Second antibody alone (negative control). The
staining was performed after six months of culture.
Characterization of Surface Antigen Expression
of Cell Populations by Flow Cytometry
As summarized in Table 2 and in one example of
a histogram (Fig. 5), cells from each group were
first analyzed for expression of B-cell markers
such as surface Ig (sIg) and B220 antigens as well
as the pre-B-cell marker identified by mAb G-5-2.
A significant amount of sIg cells was present in
cells from different groups after retrovirus infec-
tion. Interestingly, cells from Group 7 did not
express sIg. However, they possessed precursor
B-cell markers such as G-5-2. The expression of
B220 antigen did not correlate with sIg36 U. CHEN
TABLE 2
Percentage of Cells Expressing Positive Surface Markers in the ES-Derived Hematopoietic Cells as Analyzed
by Immunofluoresence Labeling and Flow Cytometry
Designation
(group-cell
population)
G-5-2 sIg B220 CD4 CD8 CD3 Thyl Mac1 SSEA $7
1-5 3.77 17.92 1.42 0.79 0.67 10.36 0.35 35.59 3.18 24.02
2-41 12.40 16.45 0.85 1.31 1.83 18.26 1.77 74.33 3.49 19.86
3-3 2.80 5.30 6.18 0.0 0.0 4.8 1.0 11.0 0.50 41.70
5-47 44.86 31.78 35.90 47.05 0.00 22.51 36.94 29.09 0.49 39.36
6-44 13.66 16.67 21.23 0.00 0.00 10.39 57.57 32.47 1.10 2.15
7-45 6.08 0.71 20.04 9.97 0.78 0.52 17.88 8.48 1.55 4.43
expression. Also, Thyl antigen was not always
present. The reason for this is not clear. It may
suggest that it was an unusual phenomenon
caused by the viral infection. In most groups, a
signifciant number of cells expressed CD3
antigens, although most of them were CD4-,
CD8- cells. It is very interesting that Group 7 pos-
sessed CD4
/ single positive (i.e., CD3-, CD8-)
cells. Whether these are the precursor cells
resembling stem T cells found in the adult thy-
mus (Wu et al., 1991) remains open. All groups
contained cells of the myeloid lineages as defined
by the mAb Mac-1. In all groups, most of the cells
did not express SSEA-1 antigen, which appeared
only at the blastocyst stage (Solter and Knowles,
1978), but retained various portions of embryonic
antigen recognizeqt by the mAb $7 (see what fol-
lows for a more detailed description of these
antibodies). These data suggest that progenitor
cells, precursor lymphoid cells, and some T and B
cells exist in these mixed populations.
Cloning and Characterization of Lymphoid,
Myeloid, and Precursor Stem Cells from
ES-Derived Hematopoietic Cells
One mixed population of hematopoietic cells
established by using RIM virus infection (Group
3) was cloned on irradiated splenic feeder cells.
The cloning frequency was 1 in 10 cells, because
they were plated at 0.3 cells per wellm37 clones
out of 384 cultures containing growing cells.
According to Poisson’s distribution, about 90% of
these positive cells could be derived from a
single cell. These clones were divided into six
subgroups according to three cell-surface-marker
expressions (i.e., G-5-2, CD3, and H-2KB). Some
clones were characterized in detail by using a
panel of mAbs and flow cytometry. As shown in
Fig. 6, cells from primitive stem cells to lymphoid
and myeloid lineages were established. All
clones were grown in an ES differentiation
medium (see Materials and Methods section)
without cytokines. They have been in continuous
culture for 1 year without alteration of growth
behavior and phenotype.
All clones have lost the expression of SSEA-1
antigen, which was detected by mAb MC480
(Solter and Knowles, 1978). This antigen
expresses on cells of the blastocyst stage of
embryogenesis and is mostly lost when embry-
onic cells differentiate. Some clones have
retained embryonic antigens detected by mAb $7.
$7 has been described to detect pro-B cells
(Hardy et al., 1989). We found that it detects a
wide range of embryonic cells expressed from the
blastocyst stage to the midsomite stage on most
embryonic tissue (Chen et al., unpublished).
Thus, I use this mAb to detect the stage of differ-
entiation, the stage where the loss of antigens
detected by $7 is roughly equivalent to the stage
where increasing expression of H-2 class-I
antigen is found.
As shown in Fig. 6(A), clone 19.1 is a T-cell
clone because it expresses surface antigen of
T-cell phenotype, that is, CD3/, obTCR/, ,dTCR-,
CD4-, CD8-. Clones 3.8 in Fig. 6(B) is as pre-B-cell
clone; it expresses surface markers of precursor
B-cell phenotype G52+, B220-, sIg-. Clone 3.2 in
Fig. 6(C) is an immature myeloid cell clone; it
expresses Mac-1
/ and $7
/ phenotype. Clone 3.12
in Fig. 6(D) is a possible natural killer (NK) cell
or a precursor cell; it expresses NKI.1 surface
marker. Other hematopoiesis markers tested are
Lyl-, Ack-+, and Pgpl
/ (histograms not shown).
This clone killed sublethally irradiated adult
mice (10 out of 10) 10-14 days upon intraperi-
toneal injection. Clone 3.25 in Fig. 6(E) is aLYMPHOCYTES DIFFERENTIATED FROM ES CELLS 37
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FIGURE 5. Flow cytometric
analysis of lymphohematopoietic
cells derived from ES cells (Group
2). The numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, 1:
negative control; 2: FITC-labeled
goat antimouse /-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labelled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled mouse
antirat IgG (second antibody
control); 10: FITC-labeled MC480
(anti-SSEA-1); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. 1106 cells per
antibody staining was performed
and a minimum of 1104 cells were
analyzed per sample. Cells were
stained for cytometric analysis for 6
months of culture.38 U. CHEN
FIGURE 6. Flow cytometric
analysis of lymphoid and myeloid
cell lines derived from ES cells. (A
to E) Numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, (A) 1:
negative control; 2: FITC-labeled
goat antimouse /-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labeled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled H57-597
(anti-bTCR); 10: FITC-labeled GL3
(anti-TCR); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. The second
antibody control (FITC-labeled
mouse antirat IgG) for 11 and 12 in
A, C, D, and E were not included. B1
to 8 are the same as those indicated
in A. 9: FITC-labeled mouse antirat
IgG (second antibody control); 10:
FITC-labeled MC480 (anti-SSEA-1);
11: rat IgG antimouse $7 and FITC-
labeled mouse anti-rat IgG. 12: rat
IgG antimouse M1/70 (anti-Mac-I)
and FITC-labeled mouse antirat
IgG. (C and E) Panels are the same
as those indicated in B except 9,
which is biotin-labeled B8-24-3
(anti-H-2Kb) and PE-labeled
streptavidin. (D) Panels are the
same as those indicated in B except
9, which is FITC-labeled pK136
(anti-NKl.1). 1106 cells per
antibody staining was performed
and a minimum of 1104 cells were
analyzed per sample. "Flow
cytometric analysis was performed
after the cell clones were in culture
for 3 months.
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FIGURE 6. Flow cytometric
analysis of lymphoid and myeloid
cell lines derived from ES cells. (A
to E) Numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, (A’) 1:
negative control; 2: FITC-labeled
goat antimouse t-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labeled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled H57-597
(anti-obTCR); 10: FITC-labeled GL3
(anti-dTCR); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. The second
antibody control (FITC-labeled
mouse antirat IgG) for 11 and 12 in
A, C, D, and E were not included. B1
to 8 are the same as those indicated
in A. 9: FITC-labeled mouse antirat
IgG (second antibody control); 10:
FITC-labeled MC480 (anti-SSEA-1);
11: rat IgG antimouse $7 and FITC-
labeled mouse anti-rat IgG. 12: rat
IgG antimouse M1/70 (anti-Mac-I)
and FITC-labeled mouse antirat
IgG. (C and E) Panels are the same
as those indicated in B except 9,
which is biotin-labeled B8-24-3
(anti-H-2Kb) and PE-labeled
streptavidin. (D) Panels are the
same as those indicated in B except
9, which is FITC-labeled pK136
(anti-NKl.1). lx106 cells per
antibody staining was performed
and a minimum of lx104 cells were
analyzed per sample. Flow
cytometric analysis was performed
after the cell clones were in culture
for 3 months.40 U. CHEN
FIGURE 6. Flow cytometric
analysis of lymphoid and myeloid
cell lines derived from ES cells. (A
to E) Numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, (A) 1:
negative control; 2: FITC-labeled
goat antimouse t-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labeled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled H57-597
(anti-cbTCR); 10: FITC-labeled GL3
(anti-/dTCR); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. The second
antibody control (FITC-labeled
mouse antirat IgG) for 11 and 12 in
A, C, D, and E were not included. B1
to 8 are the same as those indicated
in A. 9: FITC-labeled mouse antirat
IgG (second antibody control); 10:
FITC-labeled MC480 (anti-SSEA-1);
11: rat IgG antimouse $7 and FITC-
labeled mouse anti-rat IgG. 12: rat
IgG antimouse M1/70 (anti-Mac-I)
and FITC-labeled mouse antirat
IgG. (C and E) Panels are the same
as those indicated in B except 9,
which is biotin-labeled B8-24-3
(anti-H-2Kb) and PE-labeled
streptavidin. (D) Panels are the
same as those indicated in B except
9, which is FITC-labeled pK136
(anti-NKl.1). 1106 cells per
antibody staining was performed
and a minimum of 1104 cells were
analyzed per sample. Flow
cytometric analysis was performed
after the cell clones were in culture
for 3 months.
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FIGURE 6. Flow cytometric
analysis of lymphoid and myeloid
cell lines derived from ES cells. (A
to E) Numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, (A) 1:
negative control; 2: FITC-labeled
goat antimouse /-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labeled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled H57-597
(anti-bTCR); 10: FITC-labeled GL3
(anti-dTCR); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. The second
antibody control (FITC-labeled
mouse antirat IgG) for 11 and 12 in
A, C, D, and E were not included. B1
to 8 are the same as those indicated
in A. 9: FITC-labeled mouse antirat
IgG (second antibody control); 10:
FITC-labeled MC480 (anti-SSEA-1);
11: rat IgG antimouse $7 and FITC-
labeled mouse anti-rat IgG. 12: rat
IgG antimouse M1/70 (anti-Mac-I)
and FITC-labeled mouse antirat
IgG. (C and E) Panels are the same
as those indicated in B except 9,
which is biotin-labeled B8-24-3
(anti-H-2Kb) and PE-labeled
streptavidin. (D) Panels are the
same as those indicated in B except
9, which is FITC-labeled pK136
(anti-NKl.1). 1106 cells per
antibody staining was performed
and a minimum of lx104 cells were
analyzed per sample. Flow
cytometric analysis was performed
after the cell clones were in culture
for 3 months.42 U. CHEN
FIGURE 6. Flow cytometric
analysis of lymphoid and myeloid
cell lines derived from ES cells. (A
to E) Numbers indicate the
percentage of positive cells of each
individual staining antibody as
indicated in each histogram, mAbs
used are indicated in each panel and
described in detail in the Materials
and Methods section. In brief, (A) 1:
negative control; 2: FITC-labeled
goat antimouse /-chain; 3: biotin-
labeled G-5-2 and PE-labeled
streptavidin; 4: FITC-labeled 14.8
(anti-B220); 5: PE-labeled GK1.5
(anti-CD4); 6: FITC-labeled 500-A2
(anti-CD3); 7: FITC-labeled 53-6-75
(anti-CD8); 8: FITC-labeled T-24
(anti-Thyl); 9: FITC-labeled H57-597
(anti-obTCR); 10: FITC-labeled GL3
(anti-dTCR); 11: rat IgG antimouse
$7 and FITC-labeled mouse antirat
IgG; 12: rat IgG antimouse M1/70
(anti-Mac-I) and FITC-labeled
mouse antirat IgG. The second
antibody control (FITC-labeled
mouse antirat IgG) for 11 and 12 in
A, C, D, and E were not included. B1
to 8 are the same as those indicated
in A. 9: FITC-labeled mouse antirat
IgG (second antibody control); 10:
FITC-labeled MC480 (anti-SSEA-1);
11: rat IgG antimouse $7 and FITC-
labeled mouse anti-rat IgG. 12: rat
IgG antimouse M1/70 (anti-Mac-I)
and FITC-labeled mouse antirat
IgG. (C and E) Panels are the same
as those indicated in B except 9,
which is biotin-labeled B8-24-3
(anti-H-2Kb) and PE-labeled
streptavidin. (D) Panels are the
same as those indicated in B except
9, which is FITC-labeled pK136
(anti-NKl.1). 1x106 cells per
antibody staining was performed
and a minimum of 1x104 cells were
analyzed per sample. Flow
cytometric analysis was performed
after the cell clones were in culture
for 3 months.
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precursor stem cell; it has lost both SSEA-1
antigen and the $7 embryonic antigen, however,
H-2K
b class-I antigen is highly expressed
(midsomite stage; Ozato et al., 1985) and this
clone is negative for all other markers used in
this study. The data suggest that using a retro-
virus (such as RIM) to infect ES fetuses, it is poss-
ible to obtain mixed populations of hemato-
poietic cells. It is also possible to establish cell
lines of lymphoid and myeloid lineages at differ-
ent stages of development.
The Hematopoietic Cells Arose from ES Cells,
Not from Feeder Cells
Extreme care was taken to ensure that hemato-
poietic cells were established from ES fetuses, not
from feeder cells. Primary embryonic feeder cells
were derived from fibroblasts of nonlymphoid
tissues. All the feeder cells were subjected to
mitomycin C treatment or irradiation to render
them incapable of dividing. The nondividing
feeder cells perished after 1-2 passages (4-5
days) in the culture, whereas the differentiation
of ES fetuses requires 11-30 days. In control
experiments, feeder cells were grown under simi-
lar conditions but without ES cells; nothing
remotely resembling embryoid bodies .or ES
fetuses was found. Al,though the feeder cells dif-
fered from the ES cells in H-2 haplotypes, undif-
ferentiated ES cell lines do not express H-2 class-I
antigens, Figs. 7(A) and (B). Low levels of H-2
class-I antigens are expressed at the midsomite
stage (day 9), and the level of expression remains
low until day 13 (Ozato et al., 1985). However,
ES-cell-derived hematopoietic cells express
H-2Kb, Fig. 7(C), as do cells of strain 129 from
which the ES cells were derived; the feeder cells
do not express this H-2K
b haplotype, Fig. 7(D). In
quantitative immunofluoresence measurements
by flow cytometry, about half of the cells were
H-2K
b positive, Fig. 7(E). These cells do not
express H-2Dd, which corresponds to the haplo-
type of the feeder cells, Fig. 7(F). ES cells and
feeder cells must be trypsinized to obtain, single
cell suspensions, and this procedure destroys the
surface antigens; hence, flow cytometric analysis
of ES cells and feeder cells -was not feasible. From
these results with H-2 typing, I conclude that the
hematopoietic cells cannot have arisen from the
feeder cells.
DISCUSSION
ES cells are cell lines cloned from the inner cell
mass (ICM) of blastocysts. In this paper, I have
described an embryonic organ culture system in
which these totipotent cells differentiate into ES
fetuses that contain various hematopoietic cells
includinglymphoid cells. Upon in vivo implan-
tation, they develop into more mature lymphoid
tissues. I have also decribed the establishment of
cell lines by using retroviruses. Mixed popu-
lations of myeloid, erythroid, megakaryoid, and
lymphoid cells were identified and clones of
several cell types were established. It is
intriguing that it is possible to infect "ES fetuses"
with retroviruses containing oncogenes. Infection
seemed to increase the cell mass and life-span of
ES fetuses up to 6 months in culture, and the cells
obtained from these ES fetuses contained lin-
eages of hematopoietic cells. This system has
ma.ny advantages for studying developmental
immunology.
There are elements described in detail in the
Materials and Methods section that are known to
be essential for lymphohematopoietic stem cells
to differentiate. The most important element is
the "healthy" status of "undifferentiated" ES
cells. LIF alone does not support any of the ES
cell lines used in this study. The STO cell line,
either alone or together with LIF, is not as sup-
portive as the primary embryonic fibroblasts
(data not shown). The periodical examination of
the undifferentiated stage of ES cells by the cri-
teria described is critical. Differentiation is found
if the embryoid bodies are allowed to move
freely, detached from a fixed environment (such
as hydrophilic plastic surface of a regular tissue
culture dish). The use of hydrophobic Heraeus
tissue culture petri dishes seems to particularly
favor the growth of ES fetuses. The daily feeding
with cold medium containing high concen-
trations of good FCS also stimulates the growth.
The feeding not only provides the nutrients but
also the gentle stirring caused by the change of
medium.
The development of ES fetuses from undiffer-
entiated ES cells is not synchronous. Embryoid
bodies grown in the same petri dish develop at
various rates. It is important to select the ES
fetuses from the original "master" dish at a criti-
cal time when all three of the following struc-
tures are present: blood islands (red in color),44 U. CHENLYMPHOCYTES DIFFERENTIATED FROM ES CELLS 45
pulsating cardiac cells, and cup-shaped struc-
ture. It is especially important to look for the
cup-shaped feature, which contains lymphoid
cells. These selected ES fetuses are then placed in
a new petri dish in groups of 5-10 and cultured
further for infection with viruses and/or
addition of interleukins. Prolonged culture in the
master dish does not result in further differen-
tiation of the embryoid bodies. Because no
exogenous stimulating factors were included in
the daily feeding medium, it was likely that the
growth and differentiation seen were the result
of factors derived from cells inside the embryoid
bodies. It appeared that the selected ES fetuses
contain "tissue" or its precursors important for
lymphoid lineage development. Implantation of
ES fetuses into adult animals gives rise to many
tissues. Among them, lymphoid vessels contain-
ing positive surface markers of T and B cells were
identifiable (this study, Fig. 2, and Chen et al., in
preparation).
Although Moloney leukemia virus long ter-
minal repetitive sequences (LTR) are inactive in
the undifferentiated F9 teratocarcinoma (Gorman
et al., 1985) and in ES cells (U. Chen, un-
published), the receptors for retrovirus must be
generated during differentiation. I have immor-
talized cell lines by using retroviruses. Abelson
viruses are shown to immortalize precursor B
cells and many other tem cells. RIM viruses are
known to immortalize plasma cells and were
tumorgenic when they were injected intraperi-
toneally into pristane primed adult mice (Clynes
et al., 1988), but this is the first indication that
RIM may be able to immortalize hematopoietic
cells. Preliminary data indicate that the vector
was stably integrated into the cell lines (U. Chen
et al., unpublished data). The establishment of
stable clones of uncommitted stem cells, T cells,
pre-B cells, myeloid cells, as well as NK cells,
indicates that lymphoid and myeloid cells exist
in the retrovirus-infected hematopoietic cell
population derived from ES fetuses.
It is possible to obtain beating cardiac muscle,
blood islands, and lymphoid-cell positive clus-
ters, the so-called "ES fetuses," from ES lines
derived from several different mouse strains. The
ES-D3 cell line has been shown to be germ-line
transmittable (Gossler et al., 1986; Doetschman et
al., 1987). Although the ES-B6 cell line does not
contribute to the germ line in vivo, I have
obtained ES fetuses from this line, established
hematopoietic cell lines, and found lymphocytes.
Thus, the ability of a line to differentiate in vitro
is not a predictor of its ability to form chimeras in
vivo.
I have demonstrated that a variety of hemato-
poietic cells could be developed in this organ cul-
ture. It takes only 2 to 3 weeks for undifferen-
tiated ES cells to progress to the fetal liver
equivalent stage. ES fetuses developed in this
culture contain pre-B cells capable of responding
to bacterial lipopolysaccharide stimulation (U.
Chen and F. Melchers, unpublished). A signifi-
cant amount of these precursor B cells possess
G-5-2 surface markers and these mitogen-
responding pre-B cells are normally found
between day 16-19 of fetal liver in mouse
embryos (Melchers, 1977; Rolink et al., 1991;
F. Melchers, personal communication).
The IL-2 and IL-7 responsive lymphocytes
appear, at the earliest, at day 12-13 during
embryogenesis (B. Imhof, personal communi-
cation). Adult thymus provides an environment
for precursor cells to mature into intrathymic
precursor cells that express mature T-cell marker
CD4 (Wu et al., 1991). Fetal thymus appears earl-
iest at day 10 of mouse embryogenesis and colon-
ization by precursor stem cells is 1 day later, and
parallels the development of fetal liver. The find-
ings of IL-2- and IL-7-responsive lymphocytes
and single CD4 cells from ES fetuses and the
establishment of the CD3
obTCR+, CD4- CD8- T-cell clone suggest that
either ES fetuses provide thymus-equivalent
environment or thymic environment is not neces-
FIGURE 7. Identification of H-2 haplotype of ES cells, feeder cells, and hematopoietic cells. Clusters of ES cells were derived
from the inner cell mass of blastocysts originated from mouse strain 129 (H-2Kb) (hollow large arrows in A and B). The
surrounding feeder cells were fibroblasts derived from the Balb/c origin (H-2Dd) (hollow small arrows in A and solid small
arrows in B). Cells in A were treated with (A) fluorescence-labeled anti-H-2K and (B) anti-H-2D antibodies. Hematopoietic cells
established from ES fetuses were treated with (C) fluoresence-labeled anti-H-2K (solid small arrows) and (D) anti-H-2D (hollow
small arrows) antibodies. These cells were also subjected to quantitative immunofluorescent analysis by flow cytometry. (E) The
histogram of the hematopoietic cells stained with anti-H-2K antibody. (F) The histogram of these cells stained with anti-H-2D
antibody. (E and F) The x-axis indicates the log fluorescence intensity and the y-axis indicates the relative cell number.46 U. CHEN
sary for the maturation of these cells. The culture
conditions described in this paper seem to be fav-
orable for the development of lymphocytes equi-
valent to these stages.
Genetic manipulation of mouse ES cells
(Thompson et al., 1989; Mansour et al., 1988;
Koller and Smithies, 1989) and germ-line trans-
mission of a specific defect (Schwartzberg et al.,
1989; Thompson et al., 1989; Zijlstra et al., 1989;
DeChiara et al., 1990; Koller et al., 1990) have
provided a very powerful tool for studying gene
function. However, if the knockout of some
genes may affect normal embryonic development
and/or the survival of the fetus, germ-line trans-
mission cannot be achieved. The in vitro system
described here may be able to provide an alter-
nate way for studying the function of these
genes.
MATERIALS AND METHODS
Maintenance and Identification of
Undifferentiated ES Cell Lines
Mouse ES cells derived from strain 129 (CCE ES
cells, 129/SV/Ev; Robertson, 1987; Schwartzberg
et al., 1989) (ES-D3, 129/Sv, XY karyotype;
Gossler et al., 1986) and C57B1/6 (ES-B6; Kemler,
unpublished) wer kindly provided by Elizabeth
Robertson (Columbia University, NY) and Rolf
Kemler (MPI for Immunbiology, Freiburg, FRG).
ES cells were kept in a humidified incubator
(37 C, 10% CO2) and fed with DMEM (Gibco,
Grand Island, NY, Cat. No. 041-01965M), sup-
plemented with 4.5 g/ml glucose, 1 mM sodium
pyruvate, 20 mM L-glutamine, penicillin (100
units/ml) (Gibco), streptomycin (100 units/ml)
(Gibco), and 15% heat-inactivated (56 C, 30 min)
preselected fetal calf serum (FCS; Seromed,
Biochrom KG, Berlin, FRG, Lot No. 2L03, or
Boehringer, Mannheim, FRG, Lot No. 60039202).
The FCS were selected following two criteria: (a)
they give a high plating efficiency of ES cells at
the undifferentiated stage (see Robertson, 1987,
p.74, for detailed procedure). The screening of
FCS requires a positive control lot of FCS for
comparison, and (b) they are supportive in the
splenic lymphoid cell culture system of Mishell
and Dutton (1967) and are classified as "good
FCS" by the Mishell’s nomenclature (see Shiigi
and Mishell, 1975; Mishell et al., 1978).
ES cells were kept undifferentiated (criteria are
described in the Results section) in 60x15-mm tis-
sue culture dishes (Falcon 3002, Becton Dickin-
son, Mountain View, CA) with nondividing
feeder cells (see what follows). ES cells were used
for less than 20 passages. ES cells, feeder cells,
and all reagents are mycoplasma-free. It is neces-
sary to maintain the cultures free of mycoplasma;
no ES fetuses were formed whenever there was
contamination.
Undifferentiated ES cells were identified in this
study by (a) morphological appearance, (b) serol-
ogy, and (c) ability to differentiate to hemato-
poietic lineages in vitro. Morphological charac-
terization of ES cells by the criteria of Robertson
(1987) was performed under the phase-contrast
microscope. Morphologically, ES cell clusters
resemble "pancakes" or "islands," and the edges
of the individual cells are not clearly distinguish-
able. Once the cells begin to grow three dimen-
sionally, and the edges of the clusters begin to be
distinct, the culture has already moved toward
"chaotic" differentiation. Undifferentiated ES
cells express a stage-specific embryonic antigen
(SSEA-1), which can be recognized by a mono-
clonal antibody, MC-480 (Solter and Knowles,
1978). When the cells start to differentiate, the
expression of SSEA-1 is lost. Immunotyping pro-
vides a very sensitive, reliable, simple, and quick
way to identify differentiated ES cells before the
apparent morphological disorder.
Feeder Cells for Maintenance of
Undifferentiated ES Cell Lines
Primary embryonic fibroblasts were used to
maintain ES cell lines at the totipotent, undiffer-
entiated stage. Embryonic fibroblasts were pre-
pared from day 13-14 mouse embryos as
described by Gossler et al. (1986) and Rolf
Kemler (Max Planck Institute for Immunobiol-
ogy, Freiburg, FRG, personal communication).
Head, thymus, fetal liver, gut, and hard tissues
were removed. The remaining tissues were
minced into small pieces with a pair of scissors,
passed through a fine sieve, and digested for
30 min in Trypsin-EDTA (lx) (Gibco). Cells from
10-15 embryos were isolated and seeded in the
medium described before and grown in one 150x
15-mm tissue culture dish (Falcon 1058). After
overnight culture, the nonadherent cells were
removed. Fibroblasts were established after threeLYMPHOCYTES DIFFERENTIATED FROM ES CELLS 47
to four passages. They were either used immedi-
ately or frozen in aliquots in liquid nitrogen
tanks. All feeder cells were rendered incapable of
division, either by treating with mitomycin C
(Sigma, St. Louis, MO, 10 flg/ml) for a minimum
of 2 hr (Martin and Evans, 1975) or irradiation
(3,000 rad). LIF alone does not support the ES
cells described in this study at the undifferen-
tiated stage. The STO cell line, either alone or
together with LIF, is not as supportive as the pri-
mary embryonic fibroblasts.
In Vitro Differentiation of ES Cells to Simple,
then Cystic Embryoid Bodies, and the Selection
of ES Fetuses
A modification of published protocols (Gossler et
al., 1986; Robertson, 1987) was used. Undifferen-
tiated ES cells were removed from feeder cells
and cultured in suspension using ES differen-
tiation medium (the same medium as specified
before with 10-4M 2-mercaptoethanol). Undiffer-
entiated ES cells were detached fr.om the plate
using trypsin-EDTA solution (Gibco), 1-2x105
cells were transferred to a 60x15-mm hydro-
phobic tissue culture dish (Heraeus, Heusen-
stamm, FRG) or if not available, to a 100x15-mm
bacterial culture dish (Greine Nuringer, FRG).
The small clusters of cell aggregates were grown
in suspension at 37C in a humidified incubator
with air and 5% CO2 (and not 10% CO2) for 30
days with daily change of medium (temperature
of medium must be 4 C). The clusters of cells
expand three dimensionally to form simple
embryonic bodies. Later on, complicated struc-
tures develop inside the bodies, which then
become cystic embryonic bodies. From day 11 to
30, cultures were examined, and among cystic
embryoid bodies containing complex embryonic
structures, ES fetuses were selected by the fol-
lowing criteria: the presence of beating heart
muscle cells, visceral yolk saclike blood islands,
and small lymphoid clusters contained within a
cup-shaped structure. Five to ten ESfetuses were
pooled and transferred to another 60x15-mm tis-
sue culture dish.
In Vitro and In Vivo Characterization of ES
Fetuses
ES fetuses were fixed in 4% formaldehyde in PBS,
dehydrated, and plastic embedded by standard
technique and cut to a thickness of 2/m, and
staining of the sections with Azura A and Eosin B
was performed. ES fetuses were implanted under
the kidney capsules of Balb/c Nu/Nu male mice
(Jackson Lab., Maine) of 6 weeks of age. Three
weeks later, mice were sacrificed and the mature
ES fetuses together with the kidney were
removed and frozen. Frozen sections were cut to
a thickness of 5/m on cryostat (Leitz, Wetzlan),
fixed with acetone, rehydrated in PBS containing
1% bovine serum albumin, and immunopheno-
typing was performed with FITC-labeled goat
antimouse /-chain antibody (Southern Biotech-
nology, Birmingham, AL), FITC-labeled anti-CD3
antibody (Havran et al., 1987), anti-H-2K
b class-I
antigen (K6hler et al., 1981), and Texas Red-
labeled rat antimouse IgG antibodies (Jackson
Lab., West Grove, PA). Immunofluorescence was
then evaluated using a microscope as before.
Development of Hematopoietic Cell
Populations from ES Fetuses
Cystic embryoid bodies, selected as early as day
11 when blood islands started to appear up to 30
days when the blood islands turned brown, were
immortalized by one of the following methods:
Method 1. Individual ES fetuses in separate dis-
hes were infected with one of the following retro-
viruses: (i) A-MuLV (v-abl; Rosenberg et al., 1975;
Rosenberg and Baltimore, 1976; gift of Fritz
Melchers), (ii) J2 (v-raf/mil+myc; Troppmair et al.,
1989; gift of Ulf Rapp), (iii) RIM (Ig-myc+v-Ha-
ras; Clynes et al., 1988; gift of Ken Marcu), or (iv)
myc+mil virus (v-myc+v-mil; Righi et al., 1989; gift
of Ron-hwa Lin). Virus titers were 105-106
Pfu/ml, and the infection was performed over-
night in the presence of polybrene (10flg/ml;
Sigma). After infection, ES fetuses continued to
grow for up to 6 months in culture with regular
feeding until they became 0.5-1 cm giant bodies.
Cells then detached from the bodies spon-
taneously.
Method 2. Individual ES fetuses were dis-
rupted mechanically to release single cells or
clusters of cells, which were seeded in separate
dishes at 104-105 cells/dish and either (a) infected
with retroviruses at the 1 ml/dish as before and
fed regularly with ES differentiation medium or
(b) fed with ES differentiation medium contain-
ing growth factors and/or the mitogen, concana-48 U. CHEN
valin A (ConA; Pharmacia, Uppsala; 50Bg/ml
final concentration). The growth factors included
recombinant interleukins-1 to -5 (30 U/ml final
concentration, Karasuyama and Melchers, 1988;
gifts of Fritz Melchers), which were supernatants
from IL-producing transfectants, or erythro-
poietin (1 U/ml final concentration; Sigma).
Recombinant IL-7 (100 to 200U/ml final
concentration) was a gift from Fritz Melchers.
The IL-7 was produced by a cell line transfeced
with the mouse IL-7 gene (kindly provided by
Shin-Ichi Nishikawa).
Characterization of Hematopoietic Cell
Populations Derived from ES Fetuses
Morphology. Cells were cytocentrifuged onto
glass slides, methanol fixed and, May-Grtinwald-
Giemsa stained. The preparations were then
cover slipped and evaluated using a Zeiss Axio-
scope 20 light microscope.
tor (Goodman and LeFrancois, 1989); PK136,
which recognizes NKI.1 antigen on natural killer
cells (Koo and Peppard, 1984); G-5-2, which
recognizes GP-76 on Pre-B and plasma cells
(Strasser, 1988); 14.8, which recognizes B-220
molecules on B cells (Coffman and Weissman,
1981; Kincade et al., 1981); M1/70, which recog-
nizes Mac-1 antigen on macrophages (Springer et
al., 1979); $7, which recognizes most of the
embryonic cells including pro-B cells (Hardy et
al., 1989; Chen et al., unpublished) and FITC-lab-
eled mouse antirat IgG (Jackson Lab., West
Grove, PA). All antibodies were titrated and
specificity was characterized using mouse
splenic cells and thymocytes (data not shown).
Flow cytometry was carried out with a FACS
Analyzer (Becton Dickinson, Mountain View,
CA). Fluorescence histograms were generated
with logarithmic amlSlification of fluoresence
emitted by a minimum of 1104 single viable
cells.
Immunofluoresence Analysis. Hematopoietic
cells were allowed to grow for 2-3 days on sterile
cover slips. Subsequently, the preparations were
washed in PBS, immersed in acetone for 30
seconds, air dried, and labeled with antibodies.
The antibodies used are FITC-labeled 500-A2,
which recognizes CD3 antigen on T lymphoid
cells (Havran et al., 1987); FITC-
labeled rabbit antihamster IgG F(ab)’2 fragment
and FITC-labeled goat anti-B antibodies
(Southern Biotechnology, Birmingham, AL);
FITC-labeled sheep antimouse Ig (heavy and
light chains) F(ab)’2 fragments (Silenus, Hawtho-
rotreet, Australia); 15.5.5, which recognizes H-
2D
d class-I molecules of all cells of the H-2
d
haplotype (Ozato et al., 1980); and B8-24-3, which
recognizes H-2K
b class-I molecules on all cells of
the H-2
b haplotype (K6hler et al., 1981). Immuno-
fluoresence was then evaluated under UV illumi-
nation on a Zeiss Axioscope 20 using filters for
excitation of FITC and Texas Red. Besides the
antibodies mentioned before, the following anti-
bodies were used for flow cytometric analysis:
T-24, which recognizes Thy-1 antigen (Dennert et
al., 1980); GK1.5, which recognizes CD4 mol-
ecules on T cells (Wilde et al., 1983); 53-6-75,
which recongizes CD8 molecules on T cells
(Ledbetter and Herzenberg, 1979); H57-597,
which recognizes all ob T-cell receptors (Kubo et
al., 1989); GL3 which recognizes ’d T-cell recep-
Cloning and Characterization of Lymphoid and
Myeloid Lineages from ES-Derived
Hematopoietic Cells
A mixed population of cells from RIM virus-
infected ES fetuses was cloned on feeder cells,
which were 3,000-rad /z-irradiated splenic cells
from Balb/c mice. Cloning of cell lines was per-
formed by culturing cells at 0.3 cells/well in 96-
well flat-bottomed microculture plates in the ES-
differentiation medium as described before. After
7 days, the plates were examined for cultures
showing positive growth of clones of cells under
the microscope. Clones of cells were then trans-
ferred to 24-well culture plates and then to a tis-
sue culture flask and were fed regularly. No
feeder cells were required after the cloning. The
cell-surface-marker expression of cell lines was
examined using immunofluoresence staining of
antibodies and flow cytometric analysis as
described before.
ACKNOWLEDGMENTS
thank Ursula Kaempf, Marina Kuhn, Mark Dessing,
Katerine Haft, Birgit Kugelberg, and Ho-Yan Mok for
excellent technical help; Uwe Staerz, Lynn Ogata, John
Kemp, and Fritz Melchers for antibodies; Hans Peter
Stahlberger for excellent graphic work; Marie Kosco forLYMPHOCYTES DIFFERENTIATED FROM ES CELLS 49
morphological characterization of cell lines. acknowl-
edge the generous gifts of embryonic stem cells and
kind help in establishing ES-cell technology by Rolf
Kemler, Elizabeth Robertson, and Colin Stewart. thank
Steve Bauer for helpful discussions; Roland Lauster,
Charley Steinberg, Steve Bauer, Richard Scheuermann,
and Fritz Melchers for critical reading of the manu-
script; and Nicole Schoepflin for preparing the manu-
script. am grateful to Fritz Melchers for introducing
me to the field of developmental immunology and for
his support and encouragement throughout this study.
The Basel Institute for Immunology was founded and
is supported by F. Hoffman-La Roche and Co., Ltd.,
Basel, Switzerland.
(Received April 12, 1991)
(Accepted August 7, 1991)
REFERENCES
Clynes R., Wax J., Stanton L.W., Smith-Gill S., Potter M., and
Marcu K.B. (1988). Rapid induction of IgM-secreting
murine plasmacytomas by pristane and an immunoglobu-
lin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras
retrovirus. Proc. Natl. Acad. Sci. USA 85: 6067-6071.
Coffman R.L., and Weissman I.L. (1981). B220: A B cell-
specific member of the T200 glycoprotein family. Nature
289: 681-683.
Cudennec C.A., and Johnson G.R. (1981). Presence of multi-
potential hematopoietic cells in the teratocarcinoma cul-
tures. J. Embryol. Exp. Morph. 61: 51-59.
Cudennec C.A., and Nicolas J.-F. (1977). Blood formation in a
clonal cell line of mouse teratocarcinoma. J. Embryol. Exp.
Morph. 38: 203-210.
DeChiara T.M., Efstratiadis A., and Robertson E.J. (1990). A
growth-deficiency phenotype in heterozygous mice carry-
ing an insulin-like growth factor II gene disrupted by tar-
geting. Nature 345: 78-80.
Dennert G., Hyman R., Lesley J., and Trowbridge I.S. (1980).
Effects of cytotoxic monoclonal antibody specific for T200
glycoprotein on functional lymphoid cell populations. Cell.
Immunol. 53: 350-364.
Doetschman T., Eistetter H., Katz M., Schmidt W., and
Kemler R. (1985). The in vitro development of blastocyst-
derived embryonic stem cell lines: Formation of visceral
yolk sac, blood islands and myocardium. J. Embryol. Exp.
Morph. 87: 27-45.
Doetschman T., Gregg R.G., Maeda N., Hooper M.L., Melton
D.W., Thompson S., and Smithies O. (1987). Targetted cor-
rection of a mutant HPRT gene in mouse embryonic stem
cells. Nature 330: 576-578.
Goodman T., and LeFrancois L. (1989). Intraepithelial lym-
phocytes. Anatomical site, not T cell receptor form, dictates
phenotype and function. J. Exp. Med. 170: 1569-1587.
Gorman C.M., Rigby P.W.J., and Lane D.P. (1985). Negative
regulation of viral enhancers in undifferential embryonic
stem cells. Cell 42: 519-526.
Gossler A., Doetschman T., Korn’R., Serfling E., and Kemler
R. (1986). Transgenesis by means of blastocyst-derived
embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83:
9065-9069.
Hardy R.R., Kemp J.D., and Hayakawa K. (1989). Analysis of
lymphoid population in Scid mice; detection of a potential
B lymphocyte progenitor population present at normal
levels in Scid mice by three color flow cytometry with B220
and $7. Curr. Top. Microbiol. Immunol. 152: 19-25.
Havran W.L., Poenie M., Kimura J., Tsien R., Weiss A., and
Allison J.P. (1987). Expression and function of the CD3-
antigen receptor on murine CD4/8 thymocytes. Nature 330:
170-173.
Karasuyama H., and Melchers F. (1988). Establishment of
mouse cell lines which constitutively secrete large quan-
tities of interleukin 2, 3, 4 or 5, using modified cDNA
expression vectors. Eur. J. Immunol. 18: 97-104.
Kincade P.W., Lee G., Watanabe T., Sun L., and Scheid M.P.
(1981). Antigens displayed on murine B lymphocyte pre-
cursors. J. Immunol. 127: 2262-2268.
Kohler G., Fischer-Lindahl K., and Heusser C. (1981). Charac-
terization of a monoclonal anti-H-2K antibody. In: The
Immune system, vol. 2, Steinberg C., Lefkovits I., Eds.
(Basel, Switzerland: Karger), pp. 202-208.
Koller B.H., Marrack P., Kappler J.W., and Smithies O. (1990).
Normal development of mice deficient in fl2M, MHC class
proteins, and CD8 T cells. Science 248: 1227-1230.
Koller B.H., and Smithies O. (1989). Inactivating the fl2-micro-
globulin locus in mouse embryonic stem cells by homolo-
gous recombination. Proc. Natl. Acad. Sci. USA 86:
8932-8935.
Koo G., and Peppard J. (1984). Establishment of monoclonal
anti-NKl.1 antibody. Hybridoma 3: 301-303.
Kubo R.T., Born W., Kappler J.W., Marrack P., and Pigeon M.
(1989). Characterization of a monoclonal antibody which
detects all murine ab T cell receptors. J. Immunol. 142:
2737-2743.
Labastie M.-C., Thiery J.-P., and Le Douarin N.M. (1984).
Mouse yolk sac and intraembryonic tissues produce factors
able to elicit differentiation of erythroid burst-forming
units and colony-forming units, respectively. Proc. Natl.
Acad. Sci. USA 81: 1453-1456.
Ledbetter J.A., and Herzenberg L.A. (1979). Xenogeneic
monoclonal antibodies to mouse lymphoid differentiation
antigens. Immunol. Rev. 47: 63-90.
Lindenbaum M.H., and Grosveld F.G. (1990). An in vitro glo-
bin gene switching model based on differentiated embry-
onic stem cells. Genes and Dev. 4: 2075-2085.
Mansour S.L., Thomas K.R., and Capecchi M.R. (1988). Dis-
ruption of the proto-oncogene int-2 in mouse embryo-
derived stem cells: A general strategy for targeting
mutations to non-selectable genes. Nature 336: 348-352.
Martin G.R. (1977). Teratocarcinoma and mammalian
embryogenesis. In: Cell interactions in differentiation,
Silver L.M., Martin G.R., and Strickland S., Eds. (New York:
Academic Press), pp. 59-75.
Martin G.R., and Evans M.J. (1975). Differentiation of clonal
lines of teratocarcinoma cells: Formation of embryoid
bodies in vitro. Proc. Natl. Acad. Sci. USA 72: 1441-1445.
Melchers F. (1977). B lymphocyte development in fetal liver.
Eur. J. Immunol. 7: 476-481.
Melchers F., and Abramczuk J. (1980). Murine embryonic
blood between day 10 and 13 of gestation as a source of
immature precursor B cells. Eur. J. Immunol. 10: 763-767.
Mishell R.I., Bradley L.M., Chen Y.U., Grabstein K.H., Mishell
B.B., Shiigi J.M., and Shiigi S.M. (1978). Inhibition of ster-
oid-induced immune suppression by adjuvant stimulated
accessory cells. J. Reticuloendothel. Soc. 23: 439-447.
Mishell R.I., and Dutton R.W. (1967). Immunization of dis-
sociated spleen cell cultures from normal mice. J. Exp. Med.
126: 423-428.
Ogawa M., Nishikawa S., Ikuta K., Yamamura F., Naito M.,
Takahashi K., and Nishikawa S.-I. (1988). B cell ontogeny in
murine embryo studied by a culture system with the mono-50 U. CHEN
layer of a stromal cell clone, ST2: B cell progenitor develops
first in the embryonal body rather than in the yolk sac.
EMBO J. 7: 1337-1343.
Owen J.J.T., Raff M.C., and Cooper M.D. (1975). Studies on
the generation of B lymphocytes in the mouse embryo. Eur.
J. Immunol. 5: 468-473.
Ozato K., Mayer N., and Sacks D. (1980). Hybridoma cell lines
secreting monoclonal antibodies to mouse H-2 and Ia
antigens. J. Immunol. 124: 533-540.
Ozato K., Wan Y.-J., and OrrisonB.M. (1985). Mouse major
histocompatibility class gene expression begins at mid-
somite stage and is inducible in earlier-stage embryos by
interferon. Proc. Natl. Acad. Sci. USA 82: 2427-2431.
Paige C.J., Kincade P.W., Moore M.A.S., and Lee G. (1979).
The fate of fetal and adult B-cell progenitors grafted into
immunodeficient CBA/N mice. J. Exp. Med. 150: 548-563.
Righi M., Pierani A., Boglia A., De Libero G., Mori L., Marini
V., and Ricciardi-Castagnoli P. (1989). Generation of new
oncogenic murine retroviruses by cotransfection of clones
AKR and MH2 proviruses. Oncogene 4: 223-230.
Robertson E.J. (1987). Teratocarcinomas and embryonic stem
cells, a practical approach, Robertson E.J., Ed. (Oxford,
Washington, D.C.: IRL press).
Rolink A., Kudo A., Karasuyama H., Kikuchi Y., and
Melchers F. (1991). Long-term proliferating early pre B cell
lines and clones with the potential to develop to surface Ig-
positive, mitogen reactive B cells in vitro and in vivo. EMBO
J. 10: 327-336.
Rosenberg N., and Baltimore D. (1976). A quantitative assay
for transformation of bone marrow cells by Abel.son murine
leukemia virus. J. Exp. Med. 143: 1453-1463.
Rosenberg N., Baltimore D., and Scher C.D. (1975). In vitro
transformation of lymphoid cells by Abelson murine leu-
kemia virus. Proc. Natl. Acad. Sci. USA 72: 1932-1936.
Schmitt R.M., Bruyns E., and Snodgrass H.R. (1991). Hemato-
poietic development of embryonic stem cells in vitro: Cyto-
kine and receptor gene expression. Genes & Devel. 5:
728-740.
Schwartzberg P.L., Golf S.P., and Robertson E.J. (1989). Germ-
line transmission of a c-abl mutation introduction by tar-
geted gene disruption in ES cells. Science 246: 799-803.
Shiigi S.M., and Mishell R.I. (1975). Sera and the in vitro
induction of immune responses. I. Bacterial contamination
and the generation of good fetal bovine sera. J. Immunol.
115: 741-746.
Solter D., Knowles B.B. (1978). Monoclonal antibody defining
a stage-specific mouse embryonic antigen (SSEA-1). Proc.
Natl. Acad. Sci. USA 75: 5565-5569.
Springer T., Galfr6 G., Secher D.S., and Milstein C. (1979).
Mac-l: A macrophage differentiation antigen identified by
m0noclonal antibody. Eur. J. Immunol. 9: 301-306.
Strasser A. (1988). PB76: A novel surface glycoprotein prefer-
entially expressed on mouse pre-B cells and plasma cells
detected by the monoclonal antibody G-5-2. Eur. J. Immu-
nol. 18: 1803-1810.
Thompson S., Clarke A.R., Pow A.M., Hooper M.L., and
Melton D.W. (1989). Germ line transmission and expression
of a corrected HPRT gene produced by gene targeting in
embryonic stem cells. Cell 56: 313-321.
Troppmair J., Potter M., Wan J., and Rapp U.R. (1989). An alt-
ered v-raf is required in addition to v-myc in J3V1 virus for
acceleration of murine plasmacytomagenesis. Proc. Natl.
Acad. Sci. USA 86: 9941-9945.
von Boehmer H. (1990). Developmental biology of T cells in T
cell-receptor transgenic mice. Annu. Rev. Immunol. 8:
531-536.
Wilde D.B., Marrack P., Kappler J., Dialynas D.P., and Fitch
F.W. (1983). Evidence implicating L3T4 in class II MHC
antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a)
blocks class II MHC antigen-specific proliferation, release
of lymphokines, and binding by cloned murine helper T
lymphocyte lines. J. Immunol. 131: 2178-2183.
Wiles M.V., and Keller G. (1991). Multiple hematopoietic
lineages develop from embryonic stem (ES) cells in culture
Development 111: 259-267.
Wu" L., Scollay R., Egerton M., Pearse M., Spangrude G.J., and
Shortman K. (1991). CD4 expressed on earliest T-lineage
precursor cells in the adult murine thymus. Nature 349:
71-73.
Zijlstra M., Li E., Sajjadi F., Subramani S., and Jaenish R.
(1989). Germ-line transmission of a disrupted I/a-micro-
globulin gene produced by homologous recombination in
embryonic stem cells. Nature 342: 435-438.